non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Case selection criteria (1) Diagnostic criteria 1) Diagnostic criteria of Western medicine According to the 2018 edition of the Diagnosis and Treatment Guidelines for Primary Lung Cancer the diagnostic criteria for advanced non-small cell lung cancer are pathology Diagnosed as non-small cell lung cancer (mainly including adenocarcinoma squamous cell carcinoma etc.) staged diagnosis in accordance with the International Union Against Cancer The 8th edition of lung cancer staging (Appendix 1) released by UICC in 2017 includes stages IIIB-IV. 2) Diagnostic criteria of traditional Chinese medicine According to the 2017 version of the traditional Chinese medicine diagnosis and treatment plan for lung cancer the main manifestations of lung spleen qi deficiency combined with yang deficiency syndrome are: Exhausted and weak persistent coughing with thin phlegm chest tightness and shortness of breath bloating and drowsiness swollen and loose stools pale tongue with thin coating and teeth on the edges Traces with deep and fine veins. (2) Inclusion criteria 1) Patients with advanced non-small cell lung cancer undergoing chemotherapy who meet the diagnostic criteria of both traditional Chinese and Western medicine mentioned above; 2) Age between 18 and 75 years old gender is not restricted; 3) KPS score greater than 60 points expected survival period of more than six months; 4) Be conscious and fully understand the survey questionnaire; 5) No severe impairment in heart liver or kidney function; 6) Agree to receive treatment with traditional Chinese medicine decoction; 7) Voluntarily sign an informed consent form be able to persist in receiving treatment and complete the course of treatment according to regulations.
Exclusion criteria
Exclusion criteria: exclusion criteria 1) Secondary lung cancer or concomitant with other cancers; 2) Specialized treatment is required for severe systemic complications; 3) Currently using other treatments (drug or non drug interventions) to enhance immune function; 4) There are patients who are allergic to traditional Chinese medicine Fuzheng Fuyang Tang. 5) Poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The levels of inflammatory factor indicators such as lymphocyte subsets, CCL2, CCR4, etc.; | — |
Secondary
| Measure | Time frame |
|---|---|
| European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire;Traditional Chinese Medicine Syndrome Score; | — |
Countries
China
Contacts
Chongqing Medical University Affiliated Rehabilitation Hospital